BioArctic AB
STO:BIOA B

Watchlist Manager
BioArctic AB Logo
BioArctic AB
STO:BIOA B
Watchlist
Price: 202 SEK -5.08%
Market Cap: 17.8B SEK
Have any thoughts about
BioArctic AB?
Write Note

P/FCFE
Price to FCFE

-110.5
Current
-66.5
Median
23.4
Industry
Lower than median
Lower than industry value

Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

P/FCFE
-110.5
=
Market Cap
17.9B SEK
/
FCFE
-161.5m SEK
All Countries
Close
Market Cap P/FCFE
SE
BioArctic AB
STO:BIOA B
17.9B SEK -110.5
FR
Pharnext SCA
OTC:PNEXF
6T USD -3 232 439.1
US
Abbvie Inc
NYSE:ABBV
314.9B USD 12.6
US
Amgen Inc
NASDAQ:AMGN
140.6B USD 23.9
US
Gilead Sciences Inc
NASDAQ:GILD
115.7B USD 11.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.9B USD -79.1
US
Epizyme Inc
F:EPE
94.1B EUR -424.5
AU
CSL Ltd
ASX:CSL
135.7B AUD 77.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.8B USD 23.7
US
Seagen Inc
F:SGT
39.3B EUR -58.4
NL
argenx SE
XBRU:ARGX
36B EUR -113.4
 
SE
BioArctic AB
STO:BIOA B
Average P/FCFE: 29.8
Negative Multiple: -110.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -3 232 439.1
US
Abbvie Inc
NYSE:ABBV
12.6
US
Amgen Inc
NASDAQ:AMGN
23.9
US
Gilead Sciences Inc
NASDAQ:GILD
11.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -79.1
US
E
Epizyme Inc
F:EPE
Negative Multiple: -424.5
AU
CSL Ltd
ASX:CSL
77.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
23.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.4
NL
argenx SE
XBRU:ARGX
Negative Multiple: -113.4

P/FCFE Forward Multiples

Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/FCFE
N/A
2-Years Forward
P/FCFE
N/A
3-Years Forward
P/FCFE
N/A

See Also

Discover More